Evaluating how specialty pharmacies improve access to biologic treatments in asthma patients, suggesting further research is needed.
Specialty pharmacy implementation significantly accelerated approval and showed a trend toward faster treatment initiation. Delays in administration persisted despite adjustment for patient-level factors, underscoring the role of other barriers. Larger, multi-center studies are warranted.
No takes yet. Share an insight, caveat, or question.
Scharfenberger et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: